A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202
Minehiko Inomata, Yosuke Kawashima, Ryota Saito, Daisuke Morinaga, Hitomi Nogawa, Masamichi Sato, Yohei Suzuki, Satoru Yanagisawa, Takashi Kikuchi, Daisuke Jingu, Naruo Yoshimura, Toshiyuki Harada, Eisaku Miyauchi
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
2
被引用数
(Scopus)